Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • quicksand21
    Junior Member
    • May 2010
    • 6

    Complete Genomics Variant Calls

    Hello,

    I was wondering if anyone could shed some light on the totalScore column in the VAR files produced by Complete Genomics? Specifically what do these scores mean? Is there a best practice in terms of thresholding for high confidence variants?

    Thank you in advance for your advice!
  • jason.laramie
    Junior Member
    • Feb 2011
    • 3

    #2
    Hi,
    The totalScore is a likelihood ratio test between the most likely hypothesis (e.g. genotype) and the next most likely, and we express this score in decibels (dB). Bioinformaticists will recognize dB as the basis of the Phred scale: 10 dB means the likelihood ratio is 10:1, 20 dB means 100:1, 30 dB is 1000:1, etc. The variant scores factor in quantity of evidence (read depth), quality of evidence (base call quality values), and mapping probabilities. Therefore, the score measures our confidence in calling the variant. Likewise, we produce a "refScore" value that is calculated in a similar fashion but with the numerator of the likelihood being set to homozygous reference. Finally, the refScore can be used to ask how confident we are in the position being homozygous reference (e.g. high scores = high confidence) and if not homozygous reference the totalScore will then ask how confident are we in the genotype we called.

    Scores for variants are not calibrated on an absolute scale to error rate. A score of 30 dB does not necessarily indicate that the P(error)=0.001.

    20 dB is presently the minimum score for calling a homozygous variant and 40dB is for a heterozygous variant. Based on empirical testing, these thresholds were chosen to balance call-rate accuracy. Additionally, we add another layer of calls into our assembly process which is the "no-call". Therefore, a call can be homozygous ref, something else, or no-call. The no-call results from one hypothesis not being well separated from the other hypothesizes (>20dB) and, therefore, not sure what the correct answer is.

    As for best practices, since we have thresholded these as mentioned above and generated "no-calls" when the information is not well separated for each hypothesis, most of our customers take the genotype calls "as is" without applying another filter.

    Jason Laramie, PhD
    Principal Field Application Scientist
    Complete Genomics, Inc
    Jason Laramie, PhD
    Principal Application Scientist
    Complete Genomics, Inc.

    Comment

    • karenliu
      Junior Member
      • Oct 2011
      • 1

      #3
      Hi Jason,

      A follow up question to your answer: you said
      20 dB is presently the minimum score for calling a homozygous variant and 40dB is for a heterozygous variant
      I see that each allele in a diploid locus is called separately. For example, I can have a genotype AN or GN or NN. Namely, no-calls are determined per allele bases. If this is the case, what does the homozygous vs. heterozygous variant mean in your definition above?

      Thanks.
      Karen Liu

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...